Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

Holly A F Stessman, Aatif Mansoor, Michael A. Linden, Brian Van Ness, Linda Baughn

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)220-222
Number of pages3
JournalLeukemia and Lymphoma
Volume55
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Neoplasm Drug Resistance
Boronic Acids
Cytidine Deaminase
Pyrazines
Enzyme Activation
Burkitt Lymphoma
Mutation Rate
Tumor Cell Line
Inhibitory Concentration 50
Mutation
Pharmaceutical Preparations
AICDA (activation-induced cytidine deaminase)
Bortezomib

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency. / Stessman, Holly A F; Mansoor, Aatif; Linden, Michael A.; Van Ness, Brian; Baughn, Linda.

In: Leukemia and Lymphoma, Vol. 55, No. 1, 01.01.2014, p. 220-222.

Research output: Contribution to journalLetter

Stessman, Holly A F ; Mansoor, Aatif ; Linden, Michael A. ; Van Ness, Brian ; Baughn, Linda. / Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency. In: Leukemia and Lymphoma. 2014 ; Vol. 55, No. 1. pp. 220-222.
@article{df01f1e0da024a748184ac061a87f031,
title = "Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency",
author = "Stessman, {Holly A F} and Aatif Mansoor and Linden, {Michael A.} and {Van Ness}, Brian and Linda Baughn",
year = "2014",
month = "1",
day = "1",
doi = "10.3109/10428194.2013.797575",
language = "English (US)",
volume = "55",
pages = "220--222",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

AU - Stessman, Holly A F

AU - Mansoor, Aatif

AU - Linden, Michael A.

AU - Van Ness, Brian

AU - Baughn, Linda

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84891367302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891367302&partnerID=8YFLogxK

U2 - 10.3109/10428194.2013.797575

DO - 10.3109/10428194.2013.797575

M3 - Letter

C2 - 23734619

AN - SCOPUS:84891367302

VL - 55

SP - 220

EP - 222

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1

ER -